REVANESSE OUTLINE + LIDOCAINE

REVANESSE OUTLINE + LIDOCAINE is a gel:
- Transparent, odourless and colourless, of synthetic origin and water-based.
- Based on smooth and viscous hyaluronic acid.
- The formulation is hydrophilic and fully biocompatible, promotes limited migration of surrounding tissue and stimulates natural volume regeneration

- PROLLENIUM MEDICAL TECHNOLOGIES INC.
- NAME: REVANESSE OUTLINE + LIDOCAINE
- COMPOSITION: Cross-linked hyaluronic acid (high viscosity) 25 mg/ml, Lidocaine 0.3 %.
- PRESENTATION: 2 x 1.2 ml.
- NEEDLES: 2 x 29G.
- INDICATIONS: Indicated for the treatment of medium and deep facial wrinkles and lipoatrophy.
- INJECTION DEPTH: Middle part of the dermis.
- DURATION: The duration of the filler depends on the depth and area of injection, with an average of 6-12 months.
- USE: Strict medical use.

- Syringe: 2 x 1.2 ml.
- Needles: 2 x 29G.

Cheekbones, chin, jaw line, vermilion edge, lips.

Cross-linked hyaluronic acid (high viscosity) 25 mg/ml, Lidocaine 0.3 %.

- Do not inject Revanesse® Outline™ + into areas containing other fillers, as there are no clinical data on possible reactions
- Do not inject where a permanent filler or implant is present
- Hyaluronic acid products are not compatible with quaternary ammonium salts such as benzalkonium chloride; avoid contact with contaminated substances or instruments
- Do not use for breast augmentation or implants in bone, tendons, ligaments or muscles
- Avoid touching the treated area for 12 hours and exposing it to intense sun, UV, extreme heat or cold until the initial swelling and redness has disappeared
- If you are prone to cold sores, the micro-perforations caused by the needle could encourage a new appearance
- The use of aspirin, NSAIDs, St. John's Wort or high doses of vitamin E before treatment may increase bruising and bleeding
- The maximum recommended dose of lidocaine is 20 ml per 60 kg body weight per year; higher doses have not been studied
- Safety for patients under 18 or over 65 has not been established
- Patients who are visibly ill or have an active infection, flu or fever must wait for full recovery
- The product should only be used by operators with adequate training and anatomical knowledge
- It is advisable to inform patients of all possible risks and signs of possible complications before treatment

REVANESSE OUTLINE + LIDOCAINE is contraindicated in the following cases:
- Contains lidocaine and should not be used in patients with known allergies to this component
- It must not be injected into the eye contours, the periocular area or the eyelids
- Pregnant or breastfeeding women should not be treated with Revanesse® Outline™ +
- It is intended for intradermal use only and must not be injected into blood vessels, as it may cause occlusions and embolism
- Patients with a tendency to hypertrophic scars should not be treated
- Contains traces of gram-positive bacterial proteins, so it is contraindicated in the case of a known allergy to these substances
- Should not be used in conjunction with lasers, intense pulsed light, chemical peels or dermabrasion
- Should not be administered to persons under 18 years of age
- Patients with acne or other skin inflammatory conditions should not be treated
- Not suitable for patients with unrealistic expectations
- Should not be used in persons with autoimmune disorders, undergoing immunotherapy or with severe multiple allergies
- Patients with acute or chronic skin diseases near the injection site should not be treated
- Contraindicated in case of coagulation defects or anticoagulant therapies
- Patients with hypersensitivity to hyaluronic acid should not be treated

Ideal for creating volume in deep tissue and for shaping or structuring lips.